XML 36 R71.htm IDEA: XBRL DOCUMENT v3.2.0.727
Net Income Per Share - Schedule of Basic and Diluted Earnings (Loss) Per Share (Details) - USD ($)
 3 Months Ended 12 Months Ended
Jun. 30, 2015
Mar. 31, 2015
Dec. 31, 2014
 [1]
Sep. 30, 2014
Jun. 30, 2014
Mar. 31, 2014
 [2]
Dec. 31, 2013
 [3]
Sep. 30, 2013
Jun. 30, 2015
Jun. 30, 2014
Jun. 30, 2013
Numerator                      
Net income attributable to common shareholders $ 1,719,767 $ 566,011 $ 1,071,342 $ 960,435 $ 1,441,469 $ 755,125 $ (577,459) $ 1,303,876 $ 4,317,555 $ 2,923,011 $ 5,954,126
Denominator                      
Weighted average number of common shares—Basic                 32,817,456 30,895,832 28,205,467
Effect of dilutive securities:                      
Total weighted average dilutive securities                 106,562 1,668,235 3,769,664
Weighted average number of common shares and dilutive potential common shares used in diluted EPS                 32,924,018 32,564,067 31,975,131
Net income (loss) per common share - Basic (in dollars per share) $ 0.05 $ 0.02 $ 0.03 $ 0.03 $ 0.04 $ 0.02 $ (0.02) $ 0.05 $ 0.13 $ 0.09 $ 0.21
Net income (loss) per common share - Diluted (in dollars per share) $ 0.05 $ 0.02 $ 0.03 $ 0.03 $ 0.04 $ 0.02 $ (0.02) $ 0.04 $ 0.13 $ 0.09 $ 0.19
Contingent restricted stock grants                      
Effect of dilutive securities:                      
Weighted average dilutive securities                 4,422 0 0
Common stock warrants issued in connection with equity and financing transactions                      
Effect of dilutive securities:                      
Weighted average dilutive securities                 0 0 878
Stock Options and Incentive Warrants                      
Effect of dilutive securities:                      
Weighted average dilutive securities                 102,140 1,668,235 3,768,786
[1] Impacted by the November 1, 2014 reversion of the Company's 23.9% working interest and 19.0% net revenue interest in the Delhi Field.
[2] Includes $608,000 of non-recurring expenses related to the retirement of an officer of the Company.
[3] Reflects a $1.3 million restructuring charge and $0.8 million of non-recurring expenses primarily associated with the exercise of 4.0 million of 4.8 million of previously outstanding stock options and warrants.